Home › Alnylam Provides Key 2013 - 2014 Goals for RNAi Therapeutics Pipeline
 

Keywords :   


Alnylam Provides Key 2013 - 2014 Goals for RNAi Therapeutics Pipeline

2013-01-07 02:51:48| Biotech - Topix.net

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today its key "Alnylam 5x15" pipeline and partner program goals for 2013 through 2014.

Tags: key goals pipeline therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.11SHODO-X 12 7
28.11 CT 300MG RIGHT() 24
28.11Coleman
28.11CD / 88cm CDS
28.11PSA10 e
28.11YAMAHA
28.11PSA 10 HOLW91055
28.11nima
More »